Skip to main content

Market Overview

Did Ozempic Play A Role In A Man's Suicide? Family Seeks Warning Label

Share:
Did Ozempic Play A Role In A Man's Suicide? Family Seeks Warning Label

The family of a man who died by suicide is seeking a warning label on the ‘miracle’ weight loss drug Ozempic, claiming it contributed to his death, NBC News reported.

The family believes the man’s mood changes were linked to his use of Type 2 diabetes medicine.

The man, identified only as Anthony for privacy reasons, started taking Ozempic in February. By May, his family noticed a change in his usually outgoing personality, claiming he appeared fatigued and sullen. Anthony died by suicide in his Indiana home on May 14.

While Anthony had a history of depression, his family was shocked by his death and attributed it to his use of Ozempic.

“I think the Ozempic was putting these suicidal thoughts in his mind,” said Anthony’s sister.

See Also: Walmart Contemplates Multi-billion Dollar Majority Stake In ChenMed

While Ozempic and Wegovy have seen a surge in popularity, with a few patients reporting suicidal thoughts, believed to be a side effect. The European Medicines Agency and the U.K.’s Medicines and Healthcare Products Regulatory Agency are reviewing similar cases.

As of June 30, the U.S. Food and Drug Administration’s adverse event reporting system had received 59 reports of suicidal ideation, six reports of suicide attempts, and four reports of suicide-related to Ozempic. However, these numbers are self-reported and have not been verified.

Despite the family’s claims and the ongoing reviews, clinical trials did not find an association between Ozempic and suicidal thoughts. The FDA and the drug’s manufacturer, Novo Nordisk (OTC:NONOF) said they are monitoring the safety of the drug and will take appropriate actions if a new safety signal for suicidal ideation/behavior is identified.

Read Next: Contemporary art has globally outperformed the S&P 500 between 1995 and 2022. These curated pieces could do even better and you can own their shares. Click here to check them out.

Image By Natalia Varlei On Shutterstock


Engineered by Benzinga Neuro, Edited by
Pooja Rajkumari


The GPT-4 Benzinga Neuro content generation system exploits the extensive Benzinga Ecosystem, including native data, APIs, and more to create comprehensive and timely stories for you.
Learn more.


 

Related Articles (NONOF)

View Comments and Join the Discussion!

Posted-In: Ozempic self harm suicideBiotech News Health Care Media General

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com